Kristen Harrington-Smith - 15 Nov 2022 Form 4 Insider Report for ImmunoGen, Inc.

Role
SVP & CHIEF COMMERCIAL OFFICER
Signature
/s/ Renee Lentini, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
15 Nov 2022
Net transactions value
$0
Form type
4
Filing time
18 Nov 2022, 16:31:28 UTC
Previous filing
13 Jun 2022
Next filing
24 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Options Exercise $0 +25,000 $0.000000 25,000 15 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGN Restricted Stock Unit Options Exercise $0 -25,000 -33% $0.000000 50,000 15 Nov 2022 Common Stock 25,000 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Kristen Harrington-Smith is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
F2 The RSUs vest over a three-year period, with one-third of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date.